Nonalcoholic fatty liver disease (NAFLD) is generally associated with obesity, metabolic syndrome, and higher risk for cardiovascular diseases and is prevalent in obese patients. However, a small population of non-obese patients (predominantly Asian population) with relatively normal body mass index (BMI) has NAFLD. This article provides a synopsis of the study which determined the severity and the factors associated with NAFLD in obese and non-obese patients. NAFLD is one the most common liver diseases in the world.
NAFLD may progress to nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma. NAFLD is associated with obesity, metabolic syndrome (insulin resistance), cardiovascular risk factors, and is prevalent in obese patients. Traditionally in the Asian population, NAFLD is significant in patients with relatively normal body mass index (BMI). Although this…
